ACIU
Price
$2.85
Change
+$0.08 (+2.89%)
Updated
Dec 3 closing price
Capitalization
286.71M
98 days until earnings call
Intraday BUY SELL Signals
LRMR
Price
$3.47
Change
+$0.35 (+11.22%)
Updated
Dec 3 closing price
Capitalization
297M
104 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACIU vs LRMR

Header iconACIU vs LRMR Comparison
Open Charts ACIU vs LRMRBanner chart's image
AC Immune SA
Price$2.85
Change+$0.08 (+2.89%)
Volume$279.66K
Capitalization286.71M
Larimar Therapeutics
Price$3.47
Change+$0.35 (+11.22%)
Volume$1.38M
Capitalization297M
ACIU vs LRMR Comparison Chart in %
ACIU
Daily Signal:
Gain/Loss:
LRMR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACIU vs. LRMR commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a Hold and LRMR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (ACIU: $2.77 vs. LRMR: $3.12)
Brand notoriety: ACIU and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACIU: 72% vs. LRMR: 70%
Market capitalization -- ACIU: $286.71M vs. LRMR: $297M
ACIU [@Biotechnology] is valued at $286.71M. LRMR’s [@Biotechnology] market capitalization is $297M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACIU’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • ACIU’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, both ACIU and LRMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACIU’s TA Score shows that 3 TA indicator(s) are bullish while LRMR’s TA Score has 5 bullish TA indicator(s).

  • ACIU’s TA Score: 3 bullish, 5 bearish.
  • LRMR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, LRMR is a better buy in the short-term than ACIU.

Price Growth

ACIU (@Biotechnology) experienced а -4.48% price change this week, while LRMR (@Biotechnology) price change was -14.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

ACIU is expected to report earnings on Mar 12, 2026.

LRMR is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LRMR($297M) and ACIU($287M) have the same market capitalization . ACIU YTD gains are higher at: 2.593 vs. LRMR (-19.380). ACIU has higher annual earnings (EBITDA): -48.05M vs. LRMR (-108.21M). LRMR has more cash in the bank: 139M vs. ACIU (127M). LRMR has less debt than ACIU: LRMR (4.61M) vs ACIU (4.92M). ACIU has higher revenues than LRMR: ACIU (28.9M) vs LRMR (0).
ACIULRMRACIU / LRMR
Capitalization287M297M97%
EBITDA-48.05M-108.21M44%
Gain YTD2.593-19.380-13%
P/E RatioN/AN/A-
Revenue28.9M0-
Total Cash127M139M91%
Total Debt4.92M4.61M107%
FUNDAMENTALS RATINGS
ACIU vs LRMR: Fundamental Ratings
ACIU
LRMR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
4461
P/E GROWTH RATING
1..100
79100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LRMR's Valuation (20) in the null industry is somewhat better than the same rating for ACIU (62) in the Pharmaceuticals Major industry. This means that LRMR’s stock grew somewhat faster than ACIU’s over the last 12 months.

LRMR's Profit vs Risk Rating (100) in the null industry is in the same range as ACIU (100) in the Pharmaceuticals Major industry. This means that LRMR’s stock grew similarly to ACIU’s over the last 12 months.

ACIU's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as LRMR (100) in the null industry. This means that ACIU’s stock grew similarly to LRMR’s over the last 12 months.

ACIU's Price Growth Rating (44) in the Pharmaceuticals Major industry is in the same range as LRMR (61) in the null industry. This means that ACIU’s stock grew similarly to LRMR’s over the last 12 months.

ACIU's P/E Growth Rating (79) in the Pharmaceuticals Major industry is in the same range as LRMR (100) in the null industry. This means that ACIU’s stock grew similarly to LRMR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACIULRMR
RSI
ODDS (%)
N/A
Bullish Trend 7 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
81%
Bearish Trend 7 days ago
85%
Momentum
ODDS (%)
Bearish Trend 7 days ago
90%
Bullish Trend 7 days ago
86%
MACD
ODDS (%)
Bearish Trend 7 days ago
83%
Bullish Trend 7 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 7 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 7 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
73%
Bullish Trend 10 days ago
85%
Declines
ODDS (%)
Bearish Trend 17 days ago
86%
Bearish Trend 22 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 7 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ACIU
Daily Signal:
Gain/Loss:
LRMR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LQRCF3.57N/A
N/A
Black Mammoth Metals Corp
SPND2.27N/A
N/A
Spindletop Oil & Gas Co.
TOMYY29.15N/A
N/A
Tomy Co., Ltd.
CHGCF53.25N/A
N/A
Chugai Pharmaceutical Co., Ltd.
SEIBF33.00N/A
N/A
Seibu Holdings Inc.

ACIU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with PDSB. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then PDSB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACIU
1D Price
Change %
ACIU100%
+1.09%
PDSB - ACIU
34%
Loosely correlated
+6.47%
KURA - ACIU
34%
Loosely correlated
-2.53%
LRMR - ACIU
33%
Poorly correlated
-12.11%
VRTX - ACIU
32%
Poorly correlated
+1.78%
ANRO - ACIU
32%
Poorly correlated
-1.82%
More

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with ERAS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
-12.11%
ERAS - LRMR
43%
Loosely correlated
-3.50%
MLTX - LRMR
43%
Loosely correlated
-5.36%
AMLX - LRMR
42%
Loosely correlated
-3.44%
EYPT - LRMR
41%
Loosely correlated
-4.00%
OCUL - LRMR
40%
Loosely correlated
-3.93%
More